Group 1 - The Hong Kong stock market saw a significant rise in dairy stocks, with Australia Asia Group increasing by over 37%, Modern Dairy by 15%, and other companies like Original Ecology Dairy and China Shengmu rising over 10% [1][2] - The Chinese dairy industry is undergoing a strategic transformation from "scale expansion" to "value enhancement," driven by global supply chain adjustments and consumption upgrades [1] - Solid dairy products such as cheese and butter are becoming key drivers for innovation in the catering industry and the development of healthy food, with the B-end dairy product market expected to exceed 40 billion yuan by 2024 and reach 70.3 billion yuan by 2028 [1] Group 2 - Australia Asia Group's stock rose by 37.67% to a latest price of 2.010, with a total market value of 1.971 billion yuan [2] - Modern Dairy's stock increased by 15.08% to a price of 1.450, with a market capitalization of 11.478 billion yuan [2] - Other notable increases include Original Ecology Dairy at 10.53% (0.420, 0.197 billion yuan), China Shengmu at 10.23% (0.485, 0.4065 billion yuan), and YouRan Dairy at 8.44% (4.370, 17.011 billion yuan) [2]

Core Viewpoint - China Feihe held its 2024 Partner Conference in Harbin, emphasizing collaboration with partners to shape the future of the dairy industry and maintain market leadership [1][2]. Group 1: Market Performance and Product Innovation - Feihe has maintained its market leadership and increased its share in the domestic milk powder market through strong collaboration with partners and continuous innovation [2]. - The product "Xingfeifan Zhuorui," launched two years ago, has quickly become a billion-level product and is now the top-selling milk powder across all channels, significantly boosting the ultra-premium market [2]. - Feihe has invested in research and development since 2009, undertaking nearly 40 national and provincial key research projects, and leading the "14th Five-Year" key research project on "new generation infant formula" [2]. Group 2: Technological Advancements and Digital Transformation - Feihe has pioneered a fully digitalized supply chain for infant milk powder, implementing a system that allows for millisecond-level online monitoring and cell-level online testing of the production process [6]. - The company has achieved breakthroughs in key raw material preparation technologies and has established the first automated production line for lactoferrin in China, promoting high-quality development in the industry [6]. Group 3: Long-term Vision and Global Expansion - Feihe aims to build a century-old enterprise by focusing on long-term partnerships and contributions to the industry, transitioning from a pioneering company to a leading brand [8]. - The company has successfully launched its first locally produced infant formula in Canada, which is now available in 403 Walmart stores, indicating its commitment to international expansion [9]. - Feihe is also diversifying its product offerings to include youth cheese and adult functional nutrition products, targeting the multi-trillion-dollar food industry [9].

Core Viewpoint - The conference on dairy deep processing and active ingredient innovation highlighted the importance of "fresh and active" nutrition in the dairy industry, particularly in infant formula, driven by national policies and consumer upgrades [1][2]. Group 1: Industry Trends - The Chinese dairy industry is accelerating its transition towards high-quality development, with "freshness and activation" being identified as core themes for the entire sector [1]. - Experts agree that retaining the natural active elements in milk is crucial for enhancing product quality and upgrading the industry [1][3]. Group 2: Company Innovations - China Feihe has made significant breakthroughs in "fresh active nutrition," achieving notable improvements in nutritional activity and absorption rates through core technology innovations [2]. - The research indicates that Feihe's Xingfeifan Zhuorui formula has achieved 2 times the nutritional activity, 6.4 times better absorption, and 3.9 times enhancement in brain neuron development compared to regular formulas [2]. - Feihe employs advanced technologies such as low-temperature extraction and membrane separation to derive active nutritional components from high-quality fresh milk, establishing a closed-loop system driven by research and product application [2][3]. Group 3: Scientific Research and Collaboration - The conference featured discussions on the importance of precise nutrition and the need for scientific research to simulate breast milk components for early brain health [3]. - The shift from single nutrient focus to synergistic effects in nutrition reflects a growing awareness of health and nutrition, posing new challenges for companies in the industry [3].

Group 1 - The conference on dairy deep processing and active ingredient innovation was held in Qiqihar, Heilongjiang, organized by the Chinese Institute of Food Science and Technology, with participation from various experts in dairy science, nutrition, and biotechnology [1] - The focus of the conference was on the latest research advancements in dairy deep processing and the core technologies for the industrialization of active nutrition, aiming to promote deep integration of industry, academia, and research [1][2] - China Feihe, a leading domestic dairy company, shared its achievements in the research and industrial practice of "new generation fresh active nutrition," covering the entire chain from fresh milk sources to scientific validation [1][3] Group 2 - The dairy industry in China is accelerating its transition to high quality driven by national policies and consumer upgrades, with "freshness and activation" being a core theme for the development of infant formula and the entire dairy sector [2] - Experts emphasized that fresh active nutrition is crucial for upgrading the industry and improving product quality, focusing on preserving the natural active elements in milk [2][3] - The integration of the entire industry chain through technological and innovative practices is essential for solving challenges related to freshness, with China’s dairy industry now being viewed globally [3] Group 3 - The shift from "single nutrition" to "synergistic effects" in nutritional science is a significant challenge, requiring detailed research and long-term investment from companies [4] - Feihe is focusing on precision nutrition innovation, exemplified by its product "Xing Fei Fan Zhuo Rui," which integrates fifteen active brain nutrients to support infant brain development [4] - The company is committed to continuous technological innovation in dairy deep processing and active ingredients, aiming to lead the industry in the new era of "fresh active nutrition" [5]

智通财经APP获悉，8月10日，乳品深加工与活性原料创新研讨会在黑龙江齐齐哈尔市举办。会议由中国食品科学技术学会组织，来自中国乳制品工业协 会、中国农业科学院、南开大学、上海交通大学、大连工业大学及中国飞鹤等机构的乳品科学、营养健康、生物科技等领域的专家代表参加了会议。与会专 家围绕乳制品深加工的最新科研进展、活性营养产业化核心技术及全链条创新实践展开深入探讨，旨在推动产学研深度融合。 作为国内乳业领军企业，中国飞鹤(06186)在会上重点分享了其"新一代鲜活营养"的研发与产业实践成果，涵盖新鲜奶源、鲜活科技、鲜活营养产品及科学 实证全链条，为行业高质量发展提供经验。 突破鲜活营养新趋势，共见行业鲜活实证 在国家政策与消费升级双重驱动下，中国乳业加速向高质量转型。与会专家一致认为，"保鲜增活"是婴配粉乃至整个乳业发展的核心命题。 中国农业科学院研究员王加启表示，鲜活营养是当前整个行业升级与产品品质提升的重要方向。保鲜增活就是最大程度的保留牛奶中的天然活性元素，使珍 贵的生物天然活性物质达到更高水平，这是整个婴配粉制造的核心，也是整个行业发展的重要方向。 实际上，破解鲜活难题需要全产业链协同创新，中国乳企正在通 ...

中婴商情总经理曹天伟表示，近期对全国部分母婴门店的调查显示，约有七成母婴店老板表示门店内奶粉价格并未上涨；另有约三成门店称价格有所调 整，但这也与育儿补贴无关，主要是产品促销策略的调整。 独立乳业分析师宋亮分析指出，2024年以来，国内奶粉行业销售有所回暖，除新生人口回升因素外，也与市场秩序恢复有关。此前为争夺市场，各奶粉品 牌进行了较长时间的价格战。2024年以来，主流奶粉企业通过控货控价，推行理性竞争策略，带动了市场价格体系的回升。他强调，这属于企业的长期市 场策略调整，并非短期行为。 此前报道，国务院新闻办公室7月30日14时举行新闻发布会，介绍育儿补贴制度及生育支持措施有关情况。根据《育儿补贴制度实施方案》，从2025年1月 1日起，对符合法律法规规定生育的3周岁以下婴幼儿发放补贴，至其年满3周岁。 近日，部分社交平台上有网友称国家公布育儿补贴后，多家国内外婴幼儿奶粉品牌产品价格出现30元到50元/罐的上涨，并呼吁抵制涨价品牌。这一消息 引发众多网友热议，并于8月6日冲上新浪热搜。 记者从伊利股份、中国飞鹤、贝因美等多家乳业上市公司了解到，相关涨价传言不实。 8月6日和7日，伊利股份、中国飞鹤、贝因美 ...

Core Viewpoint - The recent rumors regarding price increases for infant formula following the announcement of national childcare subsidies have been refuted by several major dairy companies, indicating that the market conditions do not support such price hikes [1] Company Responses - Major dairy companies including Yili (伊利股份), China Feihe (中国飞鹤), and Beingmate (贝因美) have publicly stated that they have not raised prices for their infant formula products [1] - Beingmate specifically urged consumers not to believe or spread rumors about price increases, confirming that all products remain at their previous prices [1] Market Analysis - Industry analysis suggests that the declining birth rate in China has led to an oversupply in the infant formula market, resulting in intensified competition that does not favor price increases [1] - Despite social media claims of price hikes ranging from 30 to 50 yuan per can, investigations into the pricing of major brands over the past 180 days show no overall upward trend in prices [1]

Core Viewpoint - The article addresses the recent rumors regarding price increases of infant formula following the announcement of national childcare subsidies, clarifying that major companies in the dairy industry have not raised prices due to market conditions [3][4]. Industry Analysis - The domestic infant formula market is experiencing oversupply and intensified competition due to a continuous decline in newborn population, which does not support price increases [4][7]. - The total number of children aged 0-3 in China has decreased from 50.1 million in 2018 to 28.5 million in 2023, contributing to market contraction [7]. - Despite a slight rebound in birth rates in 2024, the overall downward trend in the market is expected to persist in the short term [8]. Company Responses - Major companies such as Yili (伊利股份), China Feihe (中国飞鹤), and Beingmate (贝因美) have publicly stated that they have not increased prices for their infant formula products [4][5]. - Beingmate specifically urged consumers not to believe or spread rumors about price hikes [4]. Market Trends - A survey indicated that approximately 70% of baby store owners reported no price increases in infant formula, while about 30% noted price adjustments unrelated to childcare subsidies, primarily due to promotional strategies [8]. - Since 2024, the infant formula industry has seen some sales recovery, attributed to both the rebound in newborn numbers and the restoration of market order after a prolonged price war among brands [8].

Core Viewpoint - The current oversupply in the infant formula market does not support price increases, despite rumors of price hikes following the announcement of national childcare subsidies [1][3]. Group 1: Market Conditions - The domestic infant formula market is experiencing oversupply due to a continuous decline in the number of newborns, leading to intensified competition [1][3]. - The total number of children aged 0-3 in China has decreased from 50.1 million in 2018 to 28.5 million in 2023, contributing to market contraction [3]. - Approximately 70% of surveyed baby store owners reported that prices of infant formula have not increased, while about 30% noted price adjustments unrelated to childcare subsidies [3]. Group 2: Company Responses - Major companies such as Yili, China Feihe, and Beingmate have denied any price increases for their infant formula products, urging consumers not to believe in rumors [1]. - Beingmate stated on its investor interaction platform that all products have not seen price hikes and encouraged the public to refrain from spreading false information [1]. Group 3: Industry Trends - The infant formula industry is in a deep adjustment phase, with a slight recovery in sales observed in 2024, attributed to both a rebound in newborn numbers and the restoration of market order [4]. - Analysts indicate that the price stabilization in the infant formula market is a result of long-term strategic adjustments by companies, moving away from aggressive price competition [4].

Core Insights - The introduction of two significant childcare support policies in China is expected to positively impact the infant formula market, leading to structural benefits for companies in the sector [1][2][6] Policy Implementation - The childcare subsidy policy, effective from January 1, 2025, will provide families with 3,600 yuan annually for each child under three years old, significantly enhancing the purchasing power of families with infants [2][6] - The policy is projected to release approximately 54 billion to 86 billion yuan annually for childcare, with a substantial portion likely directed towards infant formula consumption [2][6] Market Reaction - Following the announcement of the policies, major infant formula companies such as Yili and Beingmate experienced notable stock price increases, indicating a positive market response [4][5] - Yili's stock rose to 27.57 yuan per share, while Beingmate saw a peak increase of 9.97% shortly after the policy announcement [4][5] Short-term Opportunities - The policies are expected to create new opportunities for sales in the infant formula sector, particularly for products targeting infants aged 0-3 years, with potential for both volume and price increases [6][10] - Companies like Yili and Feihe are likely to benefit from increased demand for their premium products, such as organic and specialized formulas [6][10] Strategic Shifts - The subsidy policies are anticipated to shift the strategic focus of infant formula companies towards deeper market penetration in lower-tier cities, where the impact of subsidies is expected to be more pronounced [10][12] - Companies are adjusting their product offerings and marketing strategies to cater to the subsidized demographic, with initiatives like Yili's "town station" plan and Mengniu's "subsidy selection" series [10][12] Competitive Landscape - The competition among infant formula companies is expected to intensify as they vie for the benefits of the subsidy policies, leading to increased investment in lower-tier markets [10][12] - Companies must also adapt to potential disparities in subsidy distribution and consumer demand fluctuations, necessitating flexible supply chain strategies [12]